Thursday, October 1, 2020

Immunotherapy Drug Helping Lung Cancer Patients

photo of immunotherapy vial

The immunotherapy drug Tecentriq (atezolizumab) was approved earlier this year by the U.S. Food and Drug Administration to treat patients with newly diagnosed non-small cell lung cancers (NSCLC), which comprise up to 85% of all lung tumors.



from WebMD Healthhttps://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/article_thumbnails/blog_posts/cancer/metastatic_lung_cancer_blog/1800x1200_metastatic_lung_cancer_blog.jpg https://ift.tt/2GoGlJ9
via IFTTT

0 comments:

Post a Comment